France· FR:64817495
ZIIHERA 300 mg, poudre pour solution à diluer pour perfusion
A zanidatamab product containing zanidatamab, registered in France by JAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE). The same ATC class is registered in 10 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Zanidatamab is registered in 10 of 19 countries.
Countries holding a registration under ATC L01FD07 (zanidatamab), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Zanidatamab · ATC L01FD07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ZANIDATAMAB
- Manufacturer
- JAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE)
- Country
- France (FR)
- ATC code
- L01FD07
- ATC class
- Zanidatamab
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009551082832 flacon(s) en verre de 20 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zanidatamab in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsZiihera 300 mg poeder voor concentraat voor oplossing voor infusieJazz Pharmaceuticals Ireland Limited
- CzechiaZIIHERAJazz Pharmaceuticals Ireland Ltd, Dublin
- United StatesZIIHERAJazz Pharmaceuticals, Inc.
- United KingdomZiihera 300mg powder for concentrate for solution for infusion vialsJazz Pharmaceuticals UK Ltd
- IrelandZiihera 300 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Ireland Limited
- BelgiumZiihera 300 mgJazz Pharmaceuticals Ireland
- PolandZiiheraJazz Pharmaceuticals Ireland Ltd
- SwedenZiihera 300 mg Pulver till koncentrat till infusionsvätska, lösningJazz Pharmaceuticals Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ziihera
- Liechtenstein · Ziihera
- Norway · Ziihera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/81023c12-32a3-499b-83df-1ab6710fbd7b GET /v1/drugs/81023c12-32a3-499b-83df-1ab6710fbd7b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64817495",
"date_amm": "2025-06-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/25/1931",
"substance": "ZANIDATAMAB",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about zanidatamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.